Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Increased stromal cell-derived factor-1 concentration levels in aqueous from patients with uveal melanoma.
Zerbini G, Colucci A, Maestroni A, Miserocchi E, Bandello F, Modorati G.
Melanoma Res. 2012 Feb;22(1):98-9. No abstract available.
Related citations
The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
Kuźbicki Ł, Lange D, Strączyńska-Niemiec A, Chwirot BW.
Melanoma Res. 2012 Feb;22(1):70-6.
Preclinical evaluation of the antineoplastic efficacy of 7-(2-hydroxyethyl)theophylline on melanoma cancer cells.
Lentini A, Tabolacci C, Nardi A, Mattioli P, Provenzano B, Beninati S.
Melanoma Res. 2012 Apr;22(2):133-9.
MicroRNA regulation of melanoma progression.
Bonazzi VF, Stark MS, Hayward NK.
Melanoma Res. 2012 Apr;22(2):101-13.
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
Liu H, Wei Q, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wang LE.
Melanoma Res. 2012 Apr;22(2):169-75.
The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.
Barr J, Amato CM, Robinson SE, Kounalakis N, Robinson WA.
Melanoma Res. 2012 Feb;22(1):92-5.
Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Brüggenwirth HT, Kiliç E, de Klein A.
Melanoma Res. 2012 Feb;22(1):30-7.
Regression does not significantly underestimate melanoma thickness.
Traves V, Botella-Estrada R, Requena C, Nagore E.
Melanoma Res. 2012 Feb;22(1):96-8. No abstract available.
Evaluation of self-assessed melanoma growth rate in a Mediterranean patient population.
Nikolaou VA, Sypsa V, Gogas H, Polydorou D, Hasapi V, Gagari E, Stratigos A.
Melanoma Res. 2011 Dec;21(6):560-2. No abstract available.
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
Weber JS, Amin A, Minor D, Siegel J, Berman D, O'Day SJ.
Melanoma Res. 2011 Dec;21(6):530-4.
Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial.
Hofmann MA, Hauschild A, Mohr P, Garbe C, Weichenthal M, Trefzer U, Drecoll U, Tilgen W, Schadendorf D, Kaatz M, Ulrich J.
Melanoma Res. 2011 Dec;21(6):516-23.
Risk factors for limb melanomas compared with trunk melanomas in Queensland.
Green AC, Siskind V.
Melanoma Res. 2012 Feb;22(1):86-91.
Radiotracers for different angiogenesis receptors in a melanoma model.
Oliveira ÉA, Faintuch BL, Núñez EG, Moro AM, Nanda PK, Smith CJ.
Melanoma Res. 2012 Feb;22(1):45-53.
Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.
Greenwald HS, Friedman EB, Osman I.
Melanoma Res. 2012 Feb;22(1):1-8.
The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.
Ito T, Moroi Y, Oba J, Nakahara T, Takeuchi S, Uchi H, Takahara M, Masuda T, Furue M.
Melanoma Res. 2012 Feb;22(1):38-44.
Regional lymphatic immunity in melanoma.
Grotz TE, Mansfield AS, Jakub JW, Markovic SN.
Melanoma Res. 2012 Feb;22(1):9-18.
Radiotherapy as a risk factor for malignant melanoma after childhood skin hemangioma.
Haddy N, Mousannif A, Paoletti C, Dondon MG, Shamsaldin A, Doyon F, Avril MF, Fragu P, Labbé M, Lefkopoulos D, Chavaudra J, Robert C, Diallo I, de Vathaire F.
Melanoma Res. 2012 Feb;22(1):77-85.
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V, Denys A, Voelter V, Schalenbourg A, Schnyder P, Zografos L, Leyvraz S, Delaloye AB, Prior JO.
Melanoma Res. 2012 Feb;22(1):63-9.
Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study.
Robinson DW Jr, Cormier JN, Zhao N, Uhlar CM, Revicki DA, Cella D.
Melanoma Res. 2012 Feb;22(1):54-62.
IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.
Jen EY, Poindexter NJ, Farnsworth ES, Grimm EA.
Melanoma Res. 2012 Feb;22(1):19-29.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on